These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33389520)

  • 1. Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
    Feng Y; Pai CW; Seiler K; Barnes GD
    J Thromb Thrombolysis; 2021 May; 51(4):1144-1149. PubMed ID: 33389520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate Prescription of Direct Oral Anticoagulant Starter Packs.
    Feng Y; Pai CW; Seiler K; Barnes GD
    Am J Med; 2021 Mar; 134(3):370-373.e1. PubMed ID: 32822665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication.
    Schaefer JK; Errickson J; Li Y; Kong X; Alexandris-Souphis T; Ali MA; Decamillo D; Haymart B; Kaatz S; Kline-Rogers E; Kozlowski JH; Krol GD; Shankar SR; Sood SL; Froehlich JB; Barnes GD
    JAMA Intern Med; 2021 Jun; 181(6):817-824. PubMed ID: 33871544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.
    Lutsey PL; Norby FL; Zakai NA; MacLehose RF; Chen LY; Shah S; Datta YH; Alonso A
    Curr Med Res Opin; 2019 May; 35(5):837-845. PubMed ID: 30362847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
    Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
    Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation.
    Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A
    Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist Use of a Population Management Dashboard for Safe Anticoagulant Prescribing: Evaluation of a Nationwide Implementation Effort.
    Barnes GD; Chen C; Holleman R; Errickson J; Seagull FJ; Dorsch MP; Allen AL; Spoutz P; Sussman JB
    J Am Heart Assoc; 2024 Sep; 13(18):e035859. PubMed ID: 39248259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 10. Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study.
    Bruneau A; Schwab C; Anfosso M; Fernandez C; Hindlet P
    Drugs Aging; 2019 Nov; 36(11):1047-1055. PubMed ID: 31486994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
    Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
    J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
    Qian Y; Zhang J; Li J; Weng Z
    PLoS One; 2021; 16(11):e0259199. PubMed ID: 34762667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
    Janczak DT; Mimier MK; McBane RD; Kamath PS; Simmons BS; Bott-Kitslaar DM; Lenz CJ; Vargas ER; Hodge DO; Wysokinski WE
    Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
    van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
    Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation prescribing patterns in patients with cancer.
    Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
    J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
    Sanghai S; Wong C; Wang Z; Clive P; Tran W; Waring M; Goldberg R; Hayward R; Saczynski JS; McManus DD
    J Am Heart Assoc; 2020 Mar; 9(6):e014108. PubMed ID: 32146898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation.
    Mitrovic D; Folkeringa R; Veeger N; van Roon E
    Curr Med Res Opin; 2020 Apr; 36(4):547-553. PubMed ID: 32011180
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.
    Howe Z; Naville-Cook C; Cole D
    J Thromb Thrombolysis; 2019 Feb; 47(2):280-286. PubMed ID: 30449001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.